Items where authors include "Abrams, K.R."

Article

Turner, A.J., Sammon, C., Latimer, N. orcid.org/0000-0001-5304-5585 et al. (5 more authors) (2024) Transporting comparative effectiveness evidence between countries: considerations for health technology assessments. PharmacoEconomics, 42 (2). pp. 165-176. ISSN 1170-7690

Broomfield, J. orcid.org/0000-0003-1846-2150, Abrams, K.R., Freeman, S. et al. (3 more authors) (2023) Modeling the multi‐state natural history of rare diseases with heterogeneous individual patient data: a simulation study. Statistics in Medicine. ISSN 0277-6715

Woolf, K., Melbourne, C., Bryant, L. et al. (16 more authors) (2021) The United Kingdom Research study into Ethnicity And COVID-19 outcomes in Healthcare workers (UK-REACH): protocol for a prospective longitudinal cohort study of healthcare and ancillary workers in UK healthcare settings. BMJ Open, 11 (9). e050647. ISSN 2044-6055

Latimer, N.R. orcid.org/0000-0001-5304-5585, White, I.R., Abrams, K.R. et al. (1 more author) (2019) Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? Statistical Methods in Medical Research, 28 (8). pp. 2475-2493. ISSN 0962-2802

Latimer, N. orcid.org/0000-0001-5304-5585, Abrams, K.R. and Siebert, U. (2019) Two-stage estimation to adjust for treatment switching in randomised trials: A simulation study investigating the use of inverse probability weighting instead of re-censoring. BMC Medical Research Methodology, 19. 69. ISSN 1471-2288

Latimer, N.R. orcid.org/0000-0001-5304-5585, Abrams, K.R., Lambert, P.C. et al. (2 more authors) (2018) Assessing methods for dealing with treatment switching in clinical trials: A follow-up simulation study. Statistical Methods in Medical Research, 27 (3). pp. 765-784. ISSN 0962-2802

Latimer, N.R. orcid.org/0000-0001-5304-5585, Bell, H. orcid.org/0000-0001-8054-8073, Abrams, K.R. et al. (2 more authors) (2016) Adjusting for treatment switching in the METRIC study shows further improved overall survival with trametinib compared with chemotherapy. Cancer Medicine. ISSN 2045-7634

Latimer, N., Abrams, K.R., Lambert, P.C. et al. (5 more authors) (2013) Adjusting survival time estimates to account for treatment switching in randomised controlled trials – a simulation study. HEDS Discussion Paper 13/06. (Unpublished)

Pickin, M., Cooper, C.L., Chater, T. et al. (9 more authors) (2009) The multiple sclerosis risk sharing scheme monitoring study - early results and lessons for the future. BMC Neurology, 9. Art. No.1. ISSN 1471-2377

Kennedy, A.D.M., Sculpher, M.J., Coulter, A. et al. (9 more authors) (2002) Effects of decision aids for menorrhagia on treatment choices, health outcomes, and costs: a randomized controlled trial. Journal of American Medical Association, 288 (21). pp. 2701-2708. ISSN 0098-7484

Monograph

Latimer, N.R. orcid.org/0000-0001-5304-5585, White, I.R., Abrams, K.R. et al. (1 more author) (2017) Causal inference for long-term survival in randomised trials with treatment switching: Should re-censoring be applied when estimating counterfactual survival times? Report. Health Economics & Decision Science (HEDS) Discussion Paper Series (17.09). ScHARR, University of Sheffield

Latimer, N.R., Abrams, K.R., Lambert, P.C. et al. (2 more authors) (2014) Assessing methods for dealing with treatment crossover in clinical trials: A follow-up simulation study. Discussion Paper. HEDS Discussion Paper Series (14.01). Health Economics and Decision Science, School of Health and Related Research (ScHARR), University of Sheffield , Sheffield.

Proceedings Paper

Latimer, N. orcid.org/0000-0001-5304-5585 and Abrams, K.R. (2017) To re-censor, or not to re-censor, that is the question: critical considerations when applying statistical methods to adjust for treatment switching in clinical trials. In: Value in Health. ISPOR 22nd Annual International Meeting, 20-24 May 2017, Boston, USA. Elsevier , A314-A314.